CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (760) 560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- Open-market buys, last 90 days
- $568,660
- in 3 filings
- Open-market sales, last 90 days
- $487,740
- in 3 filings
Net +$80,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-09 | Birk Brian Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2023-06-09 | PALLARES EBETUEL Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2023-06-09 | Hooker Ana Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2023-06-09 | Johnson Wendy S. Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2023-03-02 | Adawi Kamal CFO and Corporate Secretary | Sale | −3,667 | $2.30 | $8K | 188,271 |
| 2023-03-02 | Hazeltine Mark Chief Business Officer | Sale | −3,667 | 190,205 | ||
| 2023-02-27 | Adawi Kamal CFO and Corporate Secretary | Grant or award | +100,000 | 191,938 | ||
| 2023-02-27 | Hazeltine Mark Chief Business Officer | Grant or award | +100,000 | 193,872 | ||
| 2023-02-08 | Hazeltine Mark Chief Business Officer | Sale | −5,821 | $2.69 | $16K | 93,872 |
| 2023-02-08 | Adawi Kamal CFO and Corporate Secretary | Sale | −5,821 | $2.69 | $16K | 91,938 |
| 2022-12-08 | ABALLI JOHN President and CEO | Purchase | +90,000 | $2.68 | $241K | 440,000 |
| 2022-10-16 | ABALLI JOHN President and CEO | Grant or award | +350,000 | 350,000 | ||
| 2022-06-16 | Johnson Wendy S. Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2022-06-16 | PALLARES EBETUEL Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2022-06-16 | Nova Tina Susan Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2022-06-16 | TULLIS JAMES L L Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2022-06-16 | Hooker Ana Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2022-06-16 | Birk Brian Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2022-06-16 | Stokes Frank Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2022-03-01 | Zack Debra Chief Medical Officer | Shares withheld for taxes | −3,241 | $7.12 | $23K | 84,259 |
Page 4 of 7 · 126 trades